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The glycoprotein (G-protein) of rabies virus is responsible for viral attachment to the host cell surface and
induces virus neutralization antibodies. In the present study, the G-protein gene of rabies virus CVS strain
was cloned, sequenced and expressed in the yeast, Pichia pastoris, as a secreted protein, using a
simplified DO-stat control feeding strategy. This strategy involves the addition of methanol when the
dissolved oxygen (DO) level rises above the setpoint avoiding methanol accumulation and oxygen lim-
itation. The G-protein expression was evaluated by SDS-PAGE, ELISA, and western blot assays. Like native
G-protein, the recombinant G-protein was found reactive when it was challenged against specific anti-
bodies. The data indicate that the recombinant G-protein can be easily expressed and isolated, and may
be useful as a safe source in the production of diagnostic kits and subunit vaccines to prevent rabies.
© 2017 Elsevier Inc. All rights reserved.1. Introduction
Rabies is a serious disease which causes a fatal form of
encephalomyelitis in humans and animals when treatment is not
administered. The annual number of human deaths worldwide is
estimated to be 59,000 [1]. Most of these occur in developing
countries, where canine rabies is enzootic, and rabid dog bite is the
most common mode of transmission [2]. The existence of large
reservoirs of rabies virus in stray dogs and many wild animal
species represents a serious problem for humans and domestic
animals [3].
Although there is evidence that controlling dog rabies through
vaccination programs and eliminating stray dogs can reduce the
incidence of human rabies [4], exposure to rabid dogs causes more
than 99% of human deaths by rabies [5].
The rabies virus belongs in the Lyssavirus genus within the
Rhabdoviridae family. This virus has a single stranded ribonucleic
acid (RNA) genome in the negative sense orientation which en-
codes five proteins in the following order: nucleoprotein,ias Exactas, 47 y 115, 1900, La
tto).phosphoprotein, matrix protein, G-protein, and RNA dependent
RNA polymerase [6,7]. The G-protein, the only protein exposed on
the surface of the viral particle, is involved in the binding to the
cellular receptors, as well as the entry of the viral particle into the
host cell. Structure of the G-protein (a type I transmembrane pro-
tein) consists of a cytoplasmic domain, a transmembrane domain,
and an ectodomain exposed as trimers at the virus surface [8,9].
The G-protein ectodomain stimulates neutralizing antibody
production to protect vaccinated animals from rabies virus infec-
tion by inducing T lymphocytes and T helper cells [10e14].
Importantly, to stimulate immune protection by vaccination,
glycosylation of the G-protein is needed [15e17]. Therefore, it is
necessary to produce the G-protein in a eukaryotic host. In this way,
we decided to express the rabies G-protein because it is the most
antigenic and immunogenic protein in the rabies.
Vaccines are a useful tool in programs of health intervention.
Production of rabies vaccines in cell cultures and in suckling mouse
brains (also known as Fuenzalida-Palacios) [18] involves handling
live virus and is expensive. Furthermore, Fuenzalida-Palacios vac-
cine often leads to neurological complications [19].
Yeasts have been successfully used to produce viral proteins
[20,21]. The Pichia pastoris (P. pastoris) expression system was
selected because it has several technical advantages, such as site-
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post-translational modifications [22], a good leader sequence for
the secretion of recombinant protein in the medium, and it is
relatively easy to scale-up.
The closed-loop feeding strategies rely on ameasurement that is
an indicator of the metabolic state of the culture. The dissolved
oxygen (DO) concentration and pH, in microbial fermentation are
also key indicators of cellular physiology. The DO-stat control of
nutrient feeding is based on the concept of DO rises (due to a
reduction or cessation of oxygen consumption or respiration) upon
nutrient limitation or depletion. The DO-stat control maintains the
culture at a stationary DO level (the DO setpoint) by increasing the
nutrient feed rate when DO rises above the setpoint and reducing
the nutrient feed rate when DO drops below the setpoint. The DO-
stat strategy typically works well in defined media where nutrient
depletion results in rapid DO rise.
In the present study, we describe the expression of the rabies G-
protein in a Mutþ strain of P. Pastoris, GS115, during growth on
methanol under control of the strongly induced AOX1 promoter.
We also report the optimization of culture conditions for G-protein
expression by means of a DO-stat feeding strategy. The DO-stat
control feeding strategy used in this work involves the addition
of methanol when the dissolved oxygen (DO) level rises above the
setpoint. Therefore, this method avoids the methanol accumulation
and oxygen limitation.
2. Materials and methods
2.1. Strains, plasmids, and culture media
Challenge virus standard (CVS-11) strain of rabies virus.
Escherichia coli TOP100 strain, P. pastoris GS115 and pPIC9 expres-
sion vector from Invitrogen Co. (USA).
Yeast extract peptone media (YPD), buffered glycerol media
(BMG), buffered methanol media (BMM), Luria Bertani plates
containing 100 mg/ml ampicillin (LB-Amp), and minimal dextrose
plates (MD) as described in Invitrogen Pichia expression kit (USA).
Synthetic medium (SM) containing glycerol 32 g/l; KH2PO4 20 g/
l; MgSO4$7H2O 2 g/l; CaCl2$2H2O 0,3 g/l; (NH4)2SO4 15,7 g/l; 1 ml/l
of 1000 vitamins solution (biotin 0.002 g/l; pantothenate calcium
0.4 g/l; acid folic 0.002 g/l; niacin 0.4 g/l; p-aminobenzoic acid 0.2 g/
l; pyridoxine (HCl) 0.4 g/l; riboflavin 0.2 g/l; thiamine (HCl) 0.4 g/l;
Inositol 2 g/l) and 1 ml/l of 1000 micronutrients solution (boric
acid 0.05 g/l; copper sulphate 0.004 g/l; potassium iodide 0.01 g/l;
ferric chloride 0.02 g/l; manganessium sulphate 0.04 g/l; sodium
molybdate 0.02 g/l; zinc sulphate 0.04 g/l).
2.2. Amplification of rabies G-protein gene by RT-PCR
Viral RNA was isolated using TRIzol® (Invitrogen). Reverse
transcription was carried out using 1 mg of RNA, random hexamer
primers, RNAsin® (Promega), and Moloney Murine Leukemia virus
reverse transcriptase (Promega, USA). PCR on the cDNA was per-
formed with GRVF (50 ATGTCGACAAAA-
GAATGGTTCCTCAGGCTCTCCTGTTTGTACC 30) and GRVR (50
ATGAATTCTCACAGTCCGGTCTCACCCCCGCTCTTG 30) containing a
SalI and EcoRI sites, respectively. PCR was for 30 cycles (94 C for
4500, 58 C for 4500 and 72 C for 1.5 min). Electrophoresis was in 1.5%
agarose with ethidium bromide.
2.3. Generation of a recombinant P. pastoris
The purified RT-PCR product was digested with SalI and EcoRI
and ligated to the pPIC9 vector using XhoI and EcoRI restriction
sites. E.coli TOP100 competent cells were transformed byelectroporation with the pPIC9 and the G-protein open reading
frame (ORF) insert to create the pPIC9-G expression vector. Trans-
formation was confirmed by colony-PCR using specific primers to
the AOX1 region: 50AOX1 (50 GAC TGG TTC CAA TTG ACA AGC 30)
and 30AOX1 (50 GCA AAT GGC ATT CTG ACA TCC 30).
For the electroporation, 10 mg of pPIC9-G plasmid DNA was
digested in the AOX1 promoter with SacI and used to transform
40 ml of the P. pastoris competent cells (1  109 cells/ml). Recom-
binant Hisþ colonies were selected on MD plates (without histi-
dine) for 48 h at 28 C.
Colony-PCR was performed using the AOX1 primers. The PCR
sequence was compared to the rabies G-protein sequence of the
CVS strain (GenBank).
2.4. Small scale protein expression
PCR positive clones were cultured overnight at 28 C, 100 rpm in
5ml of YPDmedium. Cells were collected by centrifugation (2000g,
15 min) and resuspended in 50 fml of BMG in a 250 ml Erlenmeyer
flask for an additional 24 h. These cells were similarly resuspended
in 10 ml of BMM in a 100 ml Erlenmeyer flask for growth under the
same conditions for 72 h. Methanol was added every 24 h to a final
concentration of 0.5% (v/v). Non-transformed P. pastoris was also
cultured under similar conditions in BMG/BMM mediums supple-
mented with histidine, and used as a negative control. Supernatant
samples were taken every 24 h (0, 24, 48 and 72) and then analyzed
by SDS-PAGE and ELISA.
2.5. Detection of recombinant G-protein by ELISA
Culture supernatant protein from different time-points and
cultures were coated in a 96-well plate by mixing 100 ml of sample
with 100 ml of coating buffer (25 mM Na2CO3, NaHCO3, pH 9.6) and
incubated at 4 C overnight. Then, the plate was blocked at 37 C for
1 h with a blocking buffer containing 3% of skimmed milk powder
in 0.05% PBS-Tween followed by three washings with 0.05% PBS-
Tween.
As primary antibody, a 1:500 dilution of a monoclonal antibody
to the rabies G-protein (Santa Cruz cat. sc-57995) was added and
the samples were incubated at 37 C for 1 h. The plate was washed
three times. Then a 1:2000 dilution of an Anti-Mouse IgG e
Peroxidase conjugated antibody produced in rabbit (Sigma cat.
A9044) was added and the samples were incubated at 37 C for 1 h.
Finally, the plate was washed three times and treated with a so-
lution containing 0.03% of ATBS and 0.02% of H2O2 for 1 h in the
dark before measuring the absorbance at 405 nm.
2.6. High cell density fermentation
Batch and fed-batch cultures were performed in a 7.5 L BioFlo
310 Benchtop Bioreactor (New Brunswick-Scientific, Edison, NJ,
USA).
A starter culture (150 ml) of a SM medium was inoculated with
5 ml of an overnight culture in YPD medium of the selected clone,
and incubated at 28 C overnight. 3.85 L of fresh SM in the
fermentor was inoculated with 150 ml of a SM starter culture
(OD600nm ¼ 10). An optical density of 1 unit corresponds to
approximately 0,24 g/l of dry cell. The temperature was set at 28 C,
and the pH was adjusted to 5.
The propeller rate was set to increase to maintain the dissolved
oxygen (DO) in 40% of the saturation value during the glycerol
batch. Once glycerol depleted, a methanol feeding strategy was
designed to maintain ~40% DO automatically with a controller
regulating the methanol feed rate (BioCommand software, New
Brunswick). For 48 h of methanol induction, the feed pump was set
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if oxygen fell below 38%. Samples were taken every 12 h and
analyzed by SDS-PAGE and western blot.
Cell dry weight was measured by centrifuging a 10 ml sample at
10,000 g for 5 min discarding the upper clear broth. The cells were
washed three times with 10 ml of distilled water followed by
centrifuging at 10,000 g for 5min discarding the upper liquid. Then,
the preweighted centrifuge tube containing yeast slurry was dried
in an oven overnight at 90 C. Finally the difference in weight was
calculated and the dry weight was expressed in g/l.Fig. 1. Plasmid structure of pPIC9-G. 50 AOX1, alcohol oxidase 1 promoter; Secretion
signal, a-Factor secretion signal; 30 AOX (TT), transcriptional terminator from P. pastoris
AOX1 gene; HIS4, gene for selection; ColEI, origin of replication of colicin E1 plasmid
DNA; ampR, Ampicillin resistance gene; XhoI and EcoRI cloning sites; SacI site.2.7. SDS-PAGE and western blot assays
Samples weremixed with reducing sample buffer and separated
by 8% SDS-PAGE gel, before staining with Colloidal Coomassie
Brilliant Blue G-250 (Sigma). Bovine Serum Albumin (BSA, at
10e80 mg/ml) was used to estimate the amount of G-protein during
PAGE (TotalLab software).
Western blot samples were separated by SDS-PAGE and trans-
ferred to a polyvinylidene difluoride (PVDF) membrane (Millipore).
The membrane was blocked overnight at 4 C (5% of skimmed milk
powder in 0.1% PBS-Tween). After being washed 3  5 min (0.1%
PBS-Tween), the membrane was incubated for 1 h with a 1:200
dilution of a anti-rabies polyclonal antibody produced in rabbit by
us, with an immunization protocol at days 0, 7 and 14, using an
inactivated vaccine produced in suckling mouse brain (Zoonosis
Institute Luis Pasteur of Argentina), and subsequent bleeding at day
21. After three washings, the membrane was incubated for 1 h with
a 1:1000 dilution of an Anti-Mouse IgG e Peroxidase conjugated
produced in goat (Sigma cat. A0545). After being washed three
times, the bound antibodywas detected using a solution containing
3, 3’-diaminobenzidine (DAB) and hydrogen peroxide. In the same
way and according to the protocol suggested by themanufacturer, a
sample of the culture supernatant was analyzed by western blot
after the treatment with the enzyme EndoH (New England Biolabs
cat. P0702S) to evaluate the glycosylation of the recombinant
protein. For this assay, an anti-G-protein monoclonal antibody
produced by the cell culture laboratory of National University of
Litoral was used.3. Results
3.1. RT-PCR and generation of a recombinant P. pastoris
The G-protein was amplified by RT-PCR, cloned into pPIC9
before sequence analysis of the 1597 bp ORF (Fig. 1). Comparison to
the Genbank sequence (accession no. JX944575) a homology su-
perior to 99% was found and 4 coding differences resulting in V5A,
L10P, E408K and R523G were identified (Fig. 2). Electroporation of
SacI linearized pPIC9-G into GS115 Pichia cells generated more than
100 clones on minimal plates without histidine.3.2. Small scale protein expression and detection by ELISA and SDS-
PAGE
Supernatants of shake flask cultures from fifteen colony-PCR
positive clones were screened by ELISA in order to evaluate the
expression level. The absorbance values of only four supernatants
doubled that of the negative control and were selected for an SDS-
PAGE. The number four clone (PPRG#4) was selected for fermen-
tation analysis because it was the only one that generated a band
between 55 and 70 kDa when supernatant was analyzed by PAGE-
Coomassie, as in Fig. 4A.3.3. High cell density fermentation: Western blot and protein
quantification by SDS-PAGE
Fermentation of clone PPRG#4 was performed with the
described DO-stat method. Cell densities of PPRG#4 were calcu-
lated both for batch and fed-batch. The growth yields obtained
were 0.634 g dry cells/g glycerol and 0.073 g dry cells/g methanol.
Using this feeding strategy, it was possible to maintain the level
of dissolved oxygen around 40% of saturation (Fig. 3). The dry cell
weight in culture reached 44.92 g/l. The initial specific growth rates
were 0.258 h1 and 0.027 h1 in glycerol and methanol,
respectively.
In the SDS-PAGE assay, a band at 48 h of induction between 55
and 70 kDawas clearly visible in the culture supernatant of PPRG#4
(Fig. 4A). Using TotalLab software, the G-protein concentration and
the molecular size were estimated in 10 mg/l and 65 kDa respec-
tively. A similar sized band was recognized by anti-G-Protein an-
tibodies in a western blot assay (Fig. 4B). The mobility differences
caused by glycans were analyzed by treatment with endo H and
subsequent analysis by western bolt (Fig. 4C). G-protein has 4
predicted N-linked glycosylation sites, and an increased mobility in
SDS-PAGE was evident after the Endo H treatment.
4. Discussion
Rabies is a worldwide disease which mainly affects developing
countries. Thus, an efficient and affordable solution is needed. In
order to control and eradicate rabies, it is necessary to study new
methodologies for protein production and a quick diagnosis.
We evaluated the production of rabies virus G-protein in
P. pastoris to assess the benefit of using a DO-stat fed batch
fermentation in high density cultures.
The rabies G-protein gene was cloned in P. pastoris and
sequenced using specific primers to the G-protein gene. Sequence
comparison to the published GenBank accession number JX944575
showed over 99% of homology and identified 4 differences; none
affected the N-linked glycosylation sites described by Wiktor et al.
[10]. This is of particular interest since non-glycosylated G-protein
does not provide protective immunity [24,25]; although it still re-
mains to be see if glycosylation in the yeast will substitute for
mammalian glycosylation and support immunity.
Using P. pastoris as the expression system, the dissolved oxygen
Fig. 2. DNA and deduced amino acid sequences. The a-Factor secretion signal sequence appears underlined; first codon of G-protein is shown in bold. Below the DNA sequence,
deduced amino acid sequence is described.
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are the most important parameters for efficient protein expression
[23]. Mutþ strains of P. pastoris are sensitive to high residual
methanol concentrations [35]. When there is excess of oxygen and
methanol, formaldehyde, the first product of methanol meta-
bolism, rises to toxic levels due to its accumulation as a product of
the incomplete oxidation of methanol [35e38]. Thus, for successful
cell growth and protein expressionwithMutþ strains, it is critical to
maintain a low methanol concentration in the bioreactor. The
advantage of Mutþ strains for protein expression in relation to AOX-defective strains is their considerably faster methanol growth rate.
However, the concentration of methanol must be tightly controlled.
In order to decrease proteolytic degradation, improve protein
expression, and avoid anaerobic fermentation, a DO-stat fed batch
strategy was used to ensure a minimum concentration of methanol
and an adequate level of oxygen. Under these controlled conditions,
a high density culture was performed.
Due to the high cell density reached in P. pastoris cultures, ox-
ygen transfer limitation is relatively common in the cultivation
processes. The DO-stat feeding control proposed in this work
Fig. 3. High cell density fermentation data of PPRG#4. Time course profiles of dry cell weight (-), dissolved oxygen (), methanol flow (C) and recombinant rabies G-protein
expressed (:) in fed-batch culture with the DO-stat method. The methanol fed-batch induction was initiated at 22 h and the DO was controlled around 40%.
Fig. 4. PAGE analysis. A. Coomassie brilliant blue stained. Four times concentrated
culture supernatants (10 ml) from 48 h post methanol induction: lane 1, non-
transformed P. pastoris (negative control); lane 2, PPRG#4; lane 3, prestained molec-
ular weight markers (cat. 26616, Fermentas); lanes 4e8, 100, 200, 400, 600, 800 ng of
BSA. B. Western blot using an anti-rabies polyclonal antibody. Lane 1: prestained
molecular weight markers (cat. 26616, Fermentas); lane 2: 10 ml of inactivated vaccine
(VERORAB - SANOFI PASTEUR); the upper band is the G-protein and the band at about
55 kDa is the nucleoprotein of rabies virus; lane 3: non-transformed P. pastoris
(negative control), Lane 4: PPRG#4. C. Western blot with EndoH treatment using an
anti-G-protein monoclonal antibody. Lane 1, non-transformed P. pastoris (negative
control); lane 2, prestained molecular weight markers (cat. 26616, Fermentas); lane 3,
recombinant rabies G-protein EndoH-digested; lane 4, recombinant rabies G-protein
not digested. (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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stant set-point (40%). In this way, it was possible to increase the
concentration of biomass and the expression of the recombinant
protein without oxygen transfer limitation or the accumulation of
toxic levels of methanol. In conclusion, the DO-stat method
developed in this studymight be effective as a method for substrate
feeding in high cell density cultures.
Although the growth yield in methanol and G-protein produc-
tion level are not highwhen comparedwith similar works (Table 1),
it is interesting to note that only 24 h of inductionwere necessary to
detect the recombinant G-protein produced. Moreover, proteolytic
degradation was not observed at 48 h. G-protein production level
achieved by Nagesha et al. [33] is higher than the one we achieved.
However, their incubation period (108 h) was considerably longer
than ours and they described total proteolysis after 12 h. One of the
main causes of proteolysis in P. pastoris is methanol accumulation in
an environment without oxygen. In our opinion, this could be
avoided by using a controlled feeding strategy as described in this
work. Ben Azoun et al. [34,35] did not comment on proteolytic
degradation in their work; however, the reported levels were also 7
times lower than reported here.
The molecular size of the glycosylated recombinant G-protein
was estimated to be approximately 65 kDa and coincides with the
native rabies virus G-protein as described in previous manuscripts
[39]. Like native G-protein, the recombinant G-protein was specif-
ically recognized by anti rabies virus antibodies in western blot
assays.
These results showed that under the tested culture conditions, a
suitable expression of rabies G-protein can be achieved after a short
induction time and without proteolytic degradation. This strategy
allows culture time reduction andminimizes the cost of production
which is important for industrial applications.
Table 1
Comparison of recombinant rabies G-proteins produced in different expression systems (bacteria, plant, insect, mammalian and yeast).
System Expression level Secreted Induction Time Observation Reference
Bacteria
Escherichia coli 5.75 mg/la No 6 h Non glycosylated Singh et al. [26]
Escherichia coli 3 %b No N/D Non glycosylated, insoluble Y elverton et al. [22]
Plant
Nicotiana tabacum 0.015e0.38%c No N/D Comlicated purification Y adav et al. [27]
Nicotiana tabacum 0.38 %c No N/D Comlicated purification Ashraf et al. [28]
Insert cells
Drosophila melanogaster 39.7 mg/la No 10 d Low expression level Batista et al. [29]
Drosophila melanogaster 3 mg/la No 120 h Low expression level Ventini et al. [30]
Mammalian cells
Madin Darby bovine kidney 30 mg/ld Yes 21 d Long culture time Gupta et al. [31]
Yeast
Hansenula polymorpha 14.6 mg/ld Yes 72 h Truncated glycoprotein Qian et al. [32]
Pichia pastoris 200 mg/ld Yes 108 h Proteolytic degradation Nagesha et al. [33]
Pichia pastoris 1.23 mg/ld Yes 72 h Low expression level Azoun et al. [34]
Pichia pastoris 10 mg/ld Yes 48 h This work
a G-protein present in cell lysate.
b Grams of G-protein every 100 g of intracellular protein total.
c Grams of G-protein every 100 g of leaf protein total.
d G-protein present in culture supernatant. N/D indicates no data found.
L.D. Picotto et al. / Protein Expression and Purification 132 (2017) 124e130 129Higher levels of G-protein production may be possible with
more bioprocess optimization, such as with a focus on: longer in-
duction times, an exponential fed-batch culture and pure oxygen
administration. Almost no degradation was evident in G-protein
production after 48 h induction in this work. Further studies will be
necessary to determine if the protein is immunogenic in animal
models and if it can be used as an antigen in the development of
diagnostic kits. Such better production methods of the G-protein
will be helpful in the control and eradication of this zoonotic
disease.
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